Table 1.
Clinicopathological Features of Triple-negative and Non Triple-negative Breast Cancer
| Characteristic | Total patients N = 103 | (p value) | OR (95% CI) | ||
|---|---|---|---|---|---|
| Frequency (%) | |||||
|
TNBC
(N = 35) |
Non-TNBC
((N = 68) |
||||
| Average age (years) (mean ± SD) | 45.5 ± 9.6 | 47 ± 11.31 | |||
| Age (years) | ≤50 | 25 (71.4) | 45 (66.2) | 0.588 | 1(Ref) |
| >50 | 10 (28.6) | 23 (33.8) | 0.78 (0.32–1.90) | ||
| Menstrual history | Pre-menopausal | 13 (37.1) | 23 (33.8) | 0.738 | 1(Ref) |
| Post-menopausal | 22 (62.9) | 45 (66.2) | 1.15 (0.49–2.70) | ||
| Laterality | Right | 16 (45.7) | 23 (33.8) | 0.239 | 1(Ref) |
| Left | 19 (54.3) | 45 (66.2) | 1.64 (0.71–3.79) | ||
| Parity | ≤2 | 6 (17.1) | 23 (33.8) | 0.075 | 1(Ref) |
| >2 | 29 (82.9) | 45 (66.2) | 0.40 (0.14–1.11) | ||
| Addiction | Yes | 1 (2.9) | 3 (4.4) | 0.699 | 1(Ref) |
| No | 34 (97.1) | 65 (95.6) | 0.63 (0.06–6.36) | ||
| Past history of illness | Yes | 13 (37.1) | 26 (38.2) | 0.914 | 1(Ref) |
| No | 22 (62.9) | 42 (61.8) | 0.95 (0.41–2.21) | ||
| Breast pain | Yes | 10 (28.6) | 26 (38.2) | 0.330 | 1(Ref) |
| No | 25 (71.4) | 42 (61.8) | 0.64 (0.26–1.56) | ||
| Chemotherapy | Neo ad. | 14 (40) | 37 (54.4) | 0.166 | 1(Ref) |
| Adjuvant | 21 (60) | 31 (45.6) | 1.79 (0.79–4.06) | ||
| LN status (cN) | Negative | 11 (31.4) | 16 (23.5) | 0.388 | 1(Ref) |
| Positive | 24 (68.6) | 52 (76.5) | 1.49 (0.60–3.69) | ||
| Tumor size (cm) | 0.1–2 | 1 (2.9) | 7 (10.3) | 0.250 | 1(Ref) |
| 2.1–5 | 23 (65.7) | 35 (51.5) | 0.22 (.03–1.48) | ||
| >5 | 11 (31.4) | 26 (38.2) | 0.34 (0.05–2.45) | ||
| Stage | Early | 18 (51.4) | 24 (35.3) | 0.155 | 1(Ref) |
| Late | 17 (48.6) | 44 (64.7) | 1.94 (0.85–4.42) | ||
| Histological grade | I | 1 (2.9) | 4 (5.9) | 0.787 | 1(Ref) |
| II | 7 (20) | 14 (20.6) | 0.50 (0.07–4.25) | ||
| III | 27 (77.1) | 50 (73.5) | 0.46 (0.07–3.30) | ||
| LN status (pN) | Negative | 17 (48.6) | 24 (35.3) | 0.192 | 1(Ref) |
| Positive | 18 (51.4) | 44 (64.7) | 1.73 (0.75–3.96) | ||